← Open Payments lookup

NPI 1164976908: Open Payments

NPI 1164976908. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$83 in 3 payments from 3 companies in 2025. Trend: 2023 $869 · 2024 $1,225 · 2025 $83

Food & beverage: $63Education: $20
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.1$49
Aveo Pharmaceuticals, Inc.1$20
Gilead Sciences, Inc.1$14

Products named: FRUZAQLA, FOTIVDA, Trodelvy.